Biotech Startups

Aptatek BioSciences develops handheld, smartphone-based home monitoring tools for chronic disease patients, using a proprietary DNA aptamer assay to detect small-molecule biomarkers in real time. Its first product is an FDA Breakthrough Device-designated phenylketonuria (PKU) monitoring test that measures phenylalanine levels for at-home or point-of-care use.

1 investor

1 investor

The site presents ICON, a clinical research organization providing full-service drug development outsourcing, regulatory strategy, and clinical trial solutions for pharmaceutical and biotech sponsors. Its offerings include AI-enabled platforms for the clinical trial lifecycle, early-phase and bioanalytical services, cardiac safety monitoring, specialty laboratory services, and market access consulting.

1 investor

APT Medical manufactures and supplies medical devices for electrophysiology and vascular interventions. The company develops products for cardiology, peripheral, and neurointervention applications used by clinicians and hospitals worldwide.

1 investor

Aptose Biosciences is a biopharmaceutical company developing novel cancer therapeutics, with a focus on acute myeloid leukemia treatments. The company is advancing tuspetinib through clinical trials for AML indications.

1 investor

Aqilion is a biotech company that develops early-stage treatments for autoimmune and chronic inflammatory diseases, collaborating with specialized drug development partners. The company operates as a Swedish public limited company focused on advancing drug candidates from initial concept through clinical proof-of-concept.

1 investor

Through-the-endoscope vapor ablation platform for treating metabolic disease and type 2 diabetes via transoral duodenal ablation

1 investor

Aqua Endoscopy (Aqua Medical Inc.) develops medical device technology and conducts clinical trials to advance innovative endoscopic solutions. The company serves the medical device and healthcare sectors.

1 investor

Aqualung Therapeutics is an early-stage therapeutics company developing a drug discovery platform and pipeline focused on advancing human health. It is affiliated with the University of Florida biotech ecosystem.

1 investor

1 investor

Arakion is an early-stage biotech startup that combines AI-based protein design with experimental biology to develop peptide-based bioinsecticides with novel modes of action. Its products target high-value agricultural pests, aimed at farmers seeking selective and scalable pest management solutions.

1 investor

Aramune develops pharmaceutical and nutraceutical products targeting diseases including diabetes, obesity, cardiovascular disease, and neurodegenerative conditions. The company builds on molecular nutrition research to create treatments for the healthcare market.

1 investor

Aranda is a pharmaceutical company focused on developing and commercializing prescription and OTC products. The company leverages leadership experience in international pharmaceutical business development and product registration across European markets.

1 investor

Arborea develops sustainable nutritious food ingredients using biotechnology. The company focuses on building a net-zero, nature-positive food system for global food production.

1 investor

Arboretum provides genetic testing programs and patient registry infrastructure for healthcare systems to implement precision medicine for cardiovascular disease, cancer, and metabolic conditions. The company enables clinical integration and translational research to accelerate precision medicine trials.

1 investor

Arboretum is a venture capital firm focused on investing in early-stage healthcare entrepreneurs and portfolio companies. The firm leverages an active network of advisors with deep expertise in medical devices, diagnostics, health policy, and clinical innovation.

1 investor

Azurity Pharmaceuticals develops and commercializes innovative medicines across 10 therapeutic areas for overlooked patient populations, serving over 50 countries with a portfolio of more than 50 medicines across various dosage forms. The company uses data, analytics, and AI-driven digital tools to enhance market reach and stakeholder engagement.

1 investor

Arbutus is a biotechnology company developing therapeutic assets and bringing them to market, with expertise spanning scientific, clinical, operational, and financial development. It focuses on drug development, partnerships, and licensing deals within the biopharma sector.

1 investor

ARC Medical develops liquid medical devices, including its JOCOAT and IPCOAT products, that create a temporary physical barrier during arthroscopy, laparoscopy, or open surgery to prevent or reduce surgical adhesions. The products are aimed at improving patient recovery and are intended for surgeons and healthcare providers performing surgical procedures.

1 investor

Arcaea develops new technologies and products for the beauty industry, drawing on expertise across the supply chain to create alternatives to existing approaches.

1 investor

ArcaScience provides AI-powered benefit-risk intelligence for pharmaceutical drug development, replacing manual literature reviews and CRO services to support decision-making from candidate selection through post-marketing surveillance. The platform serves pharmaceutical teams and regulatory bodies with compliance-ready analyses.

1 investor

Archean develops in vitro platforms using human neurons for continuous drug testing, aiming to improve translatability in neurological drug research. It offers closed-loop testing across drug candidates for the treatment of neurological conditions.

1 investor

Arcoris Bio develops multiplex biomarker detection technology for researchers and clinicians in biomedical research and diagnostics. The company's MUSE technology enables precise, sensitive detection of multiple biomarkers across fields including cancer, immunology, neuroscience, and pharmaceutical research.

1 investor

Arctech is a contract research organisation (CRO) and co-development partner that helps organisations develop, test, and commercialise pest, vector, and disease detection and control technologies. It combines expertise in entomology, chemistry, public health, regulatory science, AI, and odour sensing to support product development across household pests, animal and human health, and agriculture.

1 investor